Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Board Changes

1 Nov 2024 07:00

RNS Number : 4424K
Redcentric PLC
01 November 2024
Β 

Redcentric plc

Β 

("Redcentric" or the "Group")

Β 

Board Changes

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, confirms that further to the announcement on 24 September 2024, John Radziwill has been appointed as non-executive director of the Company after completing the relevant due diligence as part of the onboarding process for all new board appointments. Mr Radziwill joins the board as a representative of ND Capital Investments Limited ("ND Capital"), one of the Company's largest shareholders, and is a highly experienced director. Mr Radziwill has held several senior leadership roles in investment banking, advisory and asset management.

Relationship Agreement

In conjunction with Mr Radziwill's appointment, the Company has entered into a relationship agreement with ND Capital. The key terms of this agreement are as follows:

Β· ND Capital has the right to nominate one person for appointment as a director of the Company providing that ND Capital (together with its individual partners and their affiliates), directly or indirectly, holds no less than 15 per cent of the voting rights of the Company (or 7.5 per cent taking into account any reduction in voting rights resulting from any dilution following the date of the agreement);

Β· All transactions, agreements or arrangements entered into between a member of the Group and ND Capital and/or any of its associates will be conducted at arm's length and on arm's length commercial terms;Β 

Β· ND Capital shall exercise its voting rights to ensure, so far as it is able to do so by the exercise of such rights, that directors independent of ND Capital shall at all times constitute a majority of the Redcentric board (save with the approval of a majority of the independent directors);

Β· ND Capital and its associates will not propose any resolution or other action to cancel the trading of the Company's shares from trading on AIM without the board's approval (save with the approval of a majority of the independent directors); and

Β· ND Capital and its associates will not solicit proxies unless consistent with the recommendation of the board, exercise powers to requisition a shareholders' meeting, orΒ undertake any action to obtain or consolidate control of the Company or seek to do so, otherwise than in accordance with the Takeover Code.

Richard McGuire, Chair of Redcentric, commented:

"John brings a wealth of expertise and experience to the Group. His addition further strengthens the Board composition and capabilities to drive execution of the Group's strategic initiatives. John represents one of the Company's long-standing and major investors through his role at ND Capital, and we look forward to his valuable insights and contributions in advancing Redcentric's strategy."

Additional information with regard to John Radziwill:

The following information is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

Full name: John Stanislas Albert Radziwill

Age: 77

Current directorships:

StoneX Group Inc.

Oryx International Growth Fund Ltd.

Seatboost Inc.

GGH Management 2 Sp. z o. o.

GGH Management 3 Sp z o.o.

StoneX Switzerland SA

Netsurion LLC (formerly known as VendorSafe Technologies Inc.)

Furnari Sp.z.o.o.

Previous directorships held in the past 5 years:

GGH MT Sp. z o. o.

Fifth Street Capital (BVI)

Β 

Save as set out above there are no further disclosures required pursuant to Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies.

Enquiries:

Redcentric plc +44 (0)800 983 2522

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

Β 

Cavendish Capital Markets Limited - Nomad and Sole Broker +44 (0)20 7220 0500

Marc Milmo / Callum Davidson / Rory Sale (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAKZMFGMMDGDZM
Date   Source Headline
1st Jun 20267:01 amRNSAppointment of Chief Financial Officer
1st Jun 20267:00 amRNSTrading Update
13th May 20261:25 pmRNSCapital Reduction Result of General Meeting
12th May 20267:00 amRNSExercise of Options
1st May 20267:00 amRNSCompletion of Sale of Redcentric Data Centres Ltd
24th Apr 20267:00 amRNSProposed Capital Reduction & Notice of GM
14th Apr 20267:00 amRNSExercise of Options
8th Apr 202612:55 pmRNSDirector/PDMR Shareholdings
19th Mar 20263:26 pmRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
23rd Feb 20261:00 pmRNSHolding(s) in Company
20th Feb 20267:00 amRNSExercise of Options
9th Jan 202610:09 amRNSExercise of Options
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 20257:00 amRNSExercise of Options
31st Dec 20257:00 amRNSExercise of Options
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
22nd Dec 202511:46 amRNSGrant of Options
22nd Dec 202511:46 amRNSGrant of Options
12th Dec 20253:49 pmRNSDirector/PDMR Shareholdings
11th Dec 20257:00 amRNSExercise of Options
10th Dec 20257:00 amRNSHalf Year Results
4th Dec 20257:00 amRNS-RPresentation via Investor Meet Company
14th Nov 20257:00 amRNSExercise of Options
6th Nov 20258:00 amRNSSAYE Share Option Scheme
5th Nov 20257:00 amRNSH1 Trading Update and Notice of Results
27th Oct 20254:36 pmRNSHolding(s) in Company
24th Oct 20257:00 amRNSExercise of Options
23rd Oct 20257:00 amRNSDisposal of Redcentric Data Centres Limited
20th Oct 20254:48 pmRNSResult of AGM
17th Oct 202512:40 pmRNSExercise of Options
13th Oct 20259:40 amRNSExercise of Options
3rd Oct 20257:00 amRNSExercise of Options
25th Sep 20257:00 amRNSPublication of Annual Report and Notice of AGM
24th Sep 20257:00 amRNSFinal Results
2nd Sep 20257:00 amRNSNotice of Final Results
22nd Aug 20251:13 pmRNSResponse to recent press speculation
19th Aug 20257:00 amRNSAppointment of Chief Financial Officer
1st Aug 20257:00 amRNSExercise of Options
7th Jul 20257:00 amRNSExercise of Options
23rd Jun 20257:00 amRNSExercise of Options
17th Jun 20257:00 amRNSHolding(s) in Company
28th May 20253:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.